Lv11
90 积分 2023-08-08 加入
Review for "Cardiovascular outcomes associated with prescription of sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with diabetes and chronic kidney disease"
14天前
已关闭
Sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus without established cardiovascular disease: Do they have a role in primary prevention?
14天前
已完结
Associations of risk factors in childhood with arterial stiffness 26 years later
19天前
已完结
Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis
22天前
已完结
Association between the fatty liver index and chronic kidney disease: the population-based KORA study
1年前
已完结
皖公网安备34019202002308
